Jci_page_head_homepage_01 Jci_page_head_homepage_02
Paul J. Egan, Kate E. Lawlor, Warren S. Alexander, Ian P. Wicks
Published in Volume 111, Issue 6
J Clin Invest. 2003; 111(6):915 doi:10.1172/JCI16156
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2008 2007 2006 2005 2004 2003 Total
Citations: 1 2 4 4 2 3 16

Citations to this article in CrossRef (16)

Title and authors Publication Year
Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs
Charles J Malemud, Andrew H Miller
Expert Opin. Ther. Targets 2008
Interferon-γ protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints
Anwen S. Williams, Peter J. Richards, Eleri Thomas, Sara Carty, Mari A. Nowell, Rhian M. Goodfellow, Colin M. Dent, Bryan D. Williams, Simon A. Jones, Nicholas Topley
Arthritis Rheum 2007
Emerging targets of biologic therapies for rheumatoid arthritis
Ingo H Tarner, Ulf Müller-Ladner, Steffen Gay
Nat Clin Pract Rheumatol 2007
Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus
R. Ni, K. Ihara, K. Miyako, M. Takemoto, M. Ishimura, H. Kohno, N. Matsuura, A. Yoshimura, T. Hara
International Journal of Immunogenetics 2006
SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation
G. M. Davey, W. R. Heath, R. Starr
Tissue Antigens 2006
Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression?
G. P. Garlet, C. R. Cardoso, A. P. Campanelli, W. Martins, J. S. Silva
J Periodontal Res 2006
Bacterial flagellin inhibits T cell receptor-mediated activation of T cells by inducing suppressor of cytokine signalling-1 (SOCS-1)
Shu Okugawa, Shintaro Yanagimoto, Kunihisa Tsukada, Takatoshi Kitazawa, Kazuhiko Koike, Satoshi Kimura, Hiroyuki Nagase, Koich Hirai, Yasuo Ota
Cellular Microbiology 2006
Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor
Kate E. Lawlor, Peter K. K. Wong, Ian K. Campbell, Nico van Rooijen, Ian P. Wicks
Arthritis Rheum 2005
Suppressors of cytokine signaling in health and disease
Jane C. Tan, Ralph Rabkin
Pediatr Nephrol 2005
Review:IL-6 Transsignaling: TheIn VivoConsequences
Simon A. Jones, Peter J. Richards, Jürgen Scheller, Stefan Rose-John
Journal of Interferon & Cytokine Research 2005